Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline (Q45098241)
scientific article published in October 2004
Language:
Current Data About Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline
(P31) (Q13442814)
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P50) (Q106082725)
(P1545) 2
(P1932) Michael J Rybak
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P304) 125-130
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P407) (Q1860)
(P887)

(P433) 2
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P478) 50
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P577) Friday, October 1, 2004
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P1433) (Q15763479)
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P1476) "Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline" (language: en)
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

(P2093) Kerry L LaPlante
(P1545) 1
(P248)
(P698) 15474322
(P813) Saturday, December 9, 2017

other details
description scientific article published in October 2004

External Links
(P356) 10.1016/J.DIAGMICROBIO.2004.06.014
(P698) 15474322
(P5875) 8242169